|Articles|May 20, 2020
Real-time MALS Determines the End Point of a Polysaccharide Depolymerization Process
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
FDA Clears Affinia’s AFTX-201 for Phase I/II BAG3 Cardiomyopathy Trial
3
Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity
4
Containment to Protection: Packaging Trends Impacting Biopharma
5